A US-based two-arm phase II trial of PT 107 in Non-small cell lung cancer.
Latest Information Update: 21 Nov 2011
Price :
$35 *
At a glance
- Drugs PT 107 (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 21 Nov 2011 New trial record